The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
2010 ◽
Vol 10
(5)
◽
pp. 1228-1237
◽
Keyword(s):
2011 ◽
Vol 11
(2)
◽
pp. 408-408
◽
Keyword(s):
2018 ◽
Vol 50
(10)
◽
pp. 3452-3459
◽
Keyword(s):
2016 ◽
Vol 30
(2)
◽
pp. 82
Keyword(s):
2019 ◽
Vol 19
(3)
◽
pp. 68
2008 ◽
Vol 40
(7)
◽
pp. 2243-2244
◽
2020 ◽
Vol 104
(10)
◽
pp. 2139-2147
◽